T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B–lineage leukemia effect

Appelbaum, 2001, Haematopoietic cell transplantation as immunotherapy., Nature., 411, 385, 10.1038/35077251 Feinstein, 2001, Reducing transplant toxicity., Curr Opin Hematol., 8, 342, 10.1097/00062752-200111000-00005 Barrett, 2000, Conditioning regimens for allogeneic stem cell transplants., Curr Opin Hematol., 7, 339, 10.1097/00062752-200011000-00003 Bearman, 1988, Regimen-related toxicity in patients undergoing bone marrow transplantation., J Clin Oncol., 6, 1562, 10.1200/JCO.1988.6.10.1562 Sullivan, 1989, Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms., N Engl J Med., 320, 828, 10.1056/NEJM198903303201303 Collins, 1997, Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation., J Clin Oncol., 15, 433, 10.1200/JCO.1997.15.2.433 Burt, 1999, Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes., Bone Marrow Transplant., 24, 1043, 10.1038/sj.bmt.1702020 Tiberghien, 2001, Use of suicide gene-expressing donor T-cells to control alloreactivity after haematopoietic stem cell transplantation., J Intern Med., 249, 369, 10.1046/j.1365-2796.2001.00809.x Bonini, 1997, HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia., Science., 276, 1719, 10.1126/science.276.5319.1719 Pion, 1995, Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy., J Clin Invest., 95, 1561, 10.1172/JCI117829 Fontaine, 2001, Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease., Nat Med., 7, 789, 10.1038/89907 Dickinson, 2002, In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens., Nat Med., 8, 410, 10.1038/nm0402-410 Mutis, 1999, Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens., Blood., 93, 2336, 10.1182/blood.V93.7.2336 Warren, 1998, Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution., Blood., 91, 2197, 10.1182/blood.V91.6.2197 Warren, 1999, CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells., Proc Natl Acad Sci U S A., 96, 8639, 10.1073/pnas.96.15.8639 Perreault, 2002, Adoptive cancer immunotherapy: discovering the best targets., J Mol Med., 80, 212, 10.1007/s00109-001-0315-1 Griem, 1991, Uneven tissue distribution of minor histocompatibility proteins versus peptides is caused by MHC expression., Cell., 65, 633, 10.1016/0092-8674(91)90095-G Barrett, 1997, Mechanisms of the graft-versus-leukemia reaction., Stem Cells., 15, 248, 10.1002/stem.150248 Eshhar, 1993, Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors., Proc Natl Acad Sci U S A., 90, 720, 10.1073/pnas.90.2.720 Maher, 2002, Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta/CD28 receptor., Nat Biotechnol., 20, 70, 10.1038/nbt0102-70 LeBien, 2000, Fates of human B-cell precursors., Blood., 96, 9, 10.1182/blood.V96.1.9.013k27_9_23 Echeverri, 2002, Immunophenotypic variability of B-cell non-Hodgkin lymphoma: a retrospective study of cases analyzed by flow cytometry., Am J Clin Pathol., 117, 615, 10.1309/AAYH-1FK8-38PL-Q6DT Hulkkonen, 2002, Surface antigen expression in chronic lymphocytic leukemia: clustering analysis, interrelationships and effects of chromosomal abnormalities., Leukemia., 16, 178, 10.1038/sj.leu.2402363 Stamenkovic, 1988, CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular immunoglobulin-like domains and an Epstein-Barr virus-related cytoplasmic tail., J Exp Med., 168, 1205, 10.1084/jem.168.3.1205 Ryan, 1997, Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity., Blood., 89, 929, 10.1182/blood.V89.3.929 Tedder, 1989, Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes: a new member of the immunoglobulin superfamily., J Immunol., 143, 712, 10.4049/jimmunol.143.2.712 Nadler, 1983, B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes., J Immunol., 131, 244, 10.4049/jimmunol.131.1.244 Uckun, 1990, Regulation of human B-cell ontogeny., Blood., 76, 1908, 10.1182/blood.V76.10.1908.1908 Horton, 1989, Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension., Gene., 77, 61, 10.1016/0378-1119(89)90359-4 Nicholson, 1997, Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukemia and lymphoma., Mol Immunol., 34, 1157, 10.1016/S0161-5890(97)00144-2 Kabat, 1991, Sequences of Proteins of Immunological Interest., 5th ed. Reddy, 2000, Elimination of Fc receptor-dependent effector functions of a modified IgG4 monoclonal antibody to human CD4., J Immunol., 164, 1925, 10.4049/jimmunol.164.4.1925 Weissman, 1988, Molecular cloning of the zeta chain of the T cell antigen receptor., Science., 239, 1018, 10.1126/science.3278377 Lupton, 1991, Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene., Mol Cell Biol., 11, 3374, 10.1128/MCB.11.6.3374 Riddell, 1990, The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells., J Immunol Methods., 128, 189, 10.1016/0022-1759(90)90210-M Stong, 1985, Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics., Blood., 65, 21, 10.1182/blood.V65.1.21.21 Fainstein, 1987, A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia., Nature., 330, 386, 10.1038/330386a0 Klein, 1968, Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines., Cancer Res., 28, 1300 Pelloquin, 1986, Human B lymphocytes immortalization by Epstein-Barr virus in the presence of cyclosporin A., In Vitro Cell Dev Biol., 22, 689, 10.1007/BF02621085 Jensen, 2000, Human T lymphocyte genetic modification with naked DNA., Mol Ther., 1, 49, 10.1006/mthe.1999.0012 Hsieh, 2000, Differential use of FasL- and perforin-mediated cytolytic mechanisms by T-cell subsets involved in graft-versus-myeloid leukemia responses., Blood., 96, 1047, 10.1182/blood.V96.3.1047.015k36_1047_1055 Kim, 1999, Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo., J Clin Invest., 103, 869, 10.1172/JCI6024 Bohmig, 1994, Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro., J Immunol., 152, 3720, 10.4049/jimmunol.152.8.3720 Chirathaworn, 2002, Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation., J Immunol., 168, 5530, 10.4049/jimmunol.168.11.5530 Holloway, 2002, Regulation of cytokine gene transcription in the immune system., Mol Immunol., 38, 567, 10.1016/S0161-5890(01)00094-3 Ye, 1997, Negative regulation of cytokine gene transcription., FASEB J., 11, 825, 10.1096/fasebj.11.11.9285480 Brouwer, 2000, Expression and induction of costimulatory and adhesion molecules on acute myeloid leukemic cells: implications for adoptive immunotherapy., Exp Hematol., 28, 161, 10.1016/S0301-472X(99)00143-5 Mielcarek, 1997, Expression of intercellular adhesion molecule 1 (ICAM-1) in childhood acute lymphoblastic leukaemia: correlation with clinical features and outcome., Br J Haematol., 96, 301, 10.1046/j.1365-2141.1997.d01-2019.x Padros, 1992, Expression of ICAM-1 (CD54) on normal and leukaemic B cells: implication for the mixed lymphocyte reaction., Clin Exp Immunol., 88, 329, 10.1111/j.1365-2249.1992.tb03082.x Jansen, 1992, Induction of CD11a/leukocyte function antigen-1 and CD54/intercellular adhesion molecule-1 on hairy cell leukemia cells is accompanied by enhanced susceptibility to T-cell but not lymphokine-activated killer-cell cytotoxicity., Blood., 80, 478, 10.1182/blood.V80.2.478.478 Cardoso, 1996, Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen., Blood., 88, 41, 10.1182/blood.V88.1.41.41 Han, 2002, Immune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells., Cytotherapy., 4, 165, 10.1080/146532402317381875 Roy, 1995, Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin., J Clin Immunol., 15, 51, 10.1007/BF01489490 Waddick, 1995, In vitro and in vivo antileukemic activity of B43-pokeweed antiviral protein against radiation-resistant human B-cell precursor leukemia cells., Blood., 86, 4228, 10.1182/blood.V86.11.4228.bloodjournal86114228 Ma, 2002, Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies., Leukemia., 16, 60, 10.1038/sj.leu.2402320 Kipriyanov, 2002, Synergistic antitumor effect of bispecific CD19 × CD3 and CD19 × CD16 diabodies in a preclinical model of non-Hodgkin's lymphoma., J Immunol., 169, 137, 10.4049/jimmunol.169.1.137 Van Der Kolk, 2002, Rituximab treatment results in impaired secondary humoral immune responsiveness., Blood., 100, 2257, 10.1182/blood.V100.6.2257.h81802002257_2257_2259 Thomis, 2001, A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease., Blood., 97, 1249, 10.1182/blood.V97.5.1249.h8001249_1249_1257 Topp, 2001, Co-expression of a CD19-specific immunoreceptor and CD28 in primary T-cells provides co-stimulation and augments efficacy in ALL and NHL [abstract]., Blood., 98, 122a Springer, 1994, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm., Cell., 76, 301, 10.1016/0092-8674(94)90337-9 Butcher, 1999, Lymphocyte trafficking and regional immunity., Adv Immunol., 72, 209, 10.1016/S0065-2776(08)60022-X Butcher, 1996, Lymphocyte homing and homeostasis., Science., 272, 60, 10.1126/science.272.5258.60 Rossig, 2002, Epstein-Barr virus-specific human T lymphocytes expressing antitumor chimeric T-cell receptors: potential for improved immunotherapy., Blood., 99, 2009, 10.1182/blood.V99.6.2009